After participating in this webinar, the learner will be able to:

1. Describe the limitations of current viral assays to diagnose CMV, EBV, and BK polyomavirus.
2. Discuss the emerging diagnostic testing including host responses for CMV and BK polyoma virus.
3. Describe the emerging concepts of the immune response to EBV that permit transition from infection to Post-Transplant Lymphoproliferative Disease.

After participating in this webinar, the learner will be able to:

1. Describe the currently recommended evaluation and administration of vaccination in the solid organ transplant candidate.
2. Discuss considerations for vaccination in solid organ transplant recipients including timing and responses.
3. Recognize the considerations for live-viral vaccination before and after solid organ transplantation, , including newly available vaccinations.

Change management is a leadership concept/strategy to lead and embed positive change in organizations and groups.  This is often part of any successful performance improvement process. 

After participating in this webinar, the learner will be able to:

1. Describe at least two change models and how to apply them.
2. Discuss change readiness and how to assess readiness.
3. Discuss the change curve during implementation of a change.
4. Describe strategies to sustain change.

After participating in this webinar, the learner will be able to:

1. Describe the incidence and clinical impact of respiratory viruses (RVs) in lung transplant recipients (LTR).
2. Explain the evidence linking RVI to chronic lung allograft dysfunction (CLAD).
3. List currently available and promising investigational therapies for: RSV, Influenza, and PIV.
4. Discuss prevention strategies.

After participating in this webinar, the learner will be able to:

• Describe an overview of genomic and epigenomic topics that are relevant to alloimmunity.
• Define epigenetics, outline basic concepts and processes.
• Outline examples of DNA methylation controlling T cell function.
• Outline examples of histone modifications controlling T cell function.
• Describe examples of epigenetic factors contributing to organ transplant rejection in rodent models.
• Describe a clinical example of epigenetic drug targeting in allogenic bone marrow transplantation to alleviate GVHD.
• Outline basic concepts in genomics and epigenomics.
• Describe 3-dimensional regulatory architectures of inflammatory genes in T cells.
• Discuss the use of 3D epigenomics to understand the basis of genetic susceptibility to inflammatory disease in humans.

After participating in this webinar, the learner will be able to:

1. Explain the advantages of tolerance vs. immune suppression.
2. Evaluate the overall status of clinical transplant tolerance and the protocols used in trials.
3. Identify current limitations to immune tolerance protocols.
4. Identify potential solutions through the use of organ and cell preservation technologies.
5. Evaluate the protocols in trials and the overall status of clinical transplant tolerance.

After participating in this webinar, the learner will be able to:

1. Discuss the effect of end organ disease and subsequent transplant on fertility in women.
2. Review the safety and efficacy of hormonal contraceptive options in transplant recipients.
3. Discuss pre-conception recommendations for transplant recipients, including timing and immunosuppression management.
4. Review maternal and fetal outcome data in both transplant recipients and living organ donors.
5. Provide resources for additional patient and provider education on reproductive health after transplantation. 

After participating in this webinar, the learner will be able to:

1. Describe the significance of post-transplant donor-specific antibodies (DSA) in the lung transplant recipients.
2. Discuss techniques used to identify post-transplant DSA in lung transplant recipients.
3. Describe possible therapeutic options used in a lung transplant recipient with DSA.

After participating in this webinar, the learner will be able to:

• To understand the current system for identifying transplant center performance under the Final Rule.
• To evaluate the current evidence of the effects of the Final rule in the field of transplantation
• To consider the benefits and limitations of revising the Final rule

After participating in this webinar, the learner will be able to:

1. Discuss the effect of end organ disease and subsequent transplant on fertility in women.
2. Review the safety and efficacy of hormonal contraceptive options in transplant recipients.
3. Discuss pre-conception recommendations for transplant recipients, including timing and immunosuppression management.
4. Review maternal and fetal outcome data in both transplant recipients and living organ donors.
5. Provide resources for additional patient and provider education on reproductive health after transplantation.